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Background
Children with JIA experience impaired QoL. Although
treatment with methotrexate (MTX) has been found to
improve QoL, some children experience difficulties in tak-
ing it. This study examined the influence of parents' atti-
tudes to MTX and treatments in general on assessment of
their child's QoL.
Methods
Mothers or fathers of 143 children aged ≥ 5 with JIA, com-
pleted questionnaires about general beliefs regarding
treatment (Treatment Representations Inventory, sub-
scales – treatment value, concerns, cure and decision sat-
isfaction) and specific beliefs regarding benefits and
difficulties in taking MTX. Core outcome variables (COV),
except ESR, were used to provide information on disease
severity. Data were analysed by correlations followed by
multiple linear regression with QoL, assessed by the Child
Health Questionnaire (CHQ), as the dependent variable.
Results
Scores on the CHQ indicated greater impairment on phys-
ical (40.2,s.d.14.6) than psychosocial (47.6,s.d.12.2)
QoL. Physical QoL was related to all COV (correlations
0.283 to -0.708), parents' views about the benefits of MTX
(r = 0.303, p < 0.001), difficulties taking MTX (r = -0.334,
p < 0.001), treatment concerns (r = -0.459, r < 0.001) and
beliefs in treatment cure (r = 0.328, p < 0.001). Psychoso-
cial QoL was related to 2 of the COV (CHAQ r = -0.427, p
< 0.001 and parent global assessment, r = -0.429, r <
0.001) plus difficulties taking MTX (r = -0.217, p < 0.01)
and treatment concerns (r = -0.426, r < 0.001). Multivari-
ate analysis indicated that general concerns about treat-
ment made a unique contribution to the explanation of
both physical and psychosocial QoL, after controlling for
disease severity.
Conclusion
Parents' concerns about treatment of JIA are important in
understanding variability in both physical and psychoso-
cial QoL of their children.
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